Covid vaccine blood clot fears have struck a second jab as the US today stopped using the Johnson & Johnson shot which the UK may approve within days. The condition in question, known as cerebral sinus venous thrombosis (CSVT), is the development of a blood clot in a vein that carries blood away from the brain. Its decision will not affect the UK's vaccine rollout for now because the Johnson & Johnson jab has not yet been approved by regulators or put into use. EUROPE REGULATOR INVESTIGATING J&J JAB CLOT CASES The European Medicines Agency last week launched a review of four blood clot cases in people who had received the Johnson & Johnson Covid vaccine. 'Treatment of this specific type of blood clot is different from the treatment that might typically be administered.

Source: The Nation April 13, 2021 13:03 UTC